Special Report: Will the COVID-19 Recovery Be Bumpier than Expected?
Though IVD and commercial lab Q3 2023 earnings reports held promising signs, Q4 2024 and FY2023 results tell a different story.
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Though IVD and commercial lab Q3 2023 earnings reports held promising signs, Q4 2024 and FY2023 results tell a different story.
From - Laboratory Industry Report
Diagnostics companies have been busy in recent months striking deals to distribute their tests or…
From - Laboratory Industry Report
The early fall season was a busy one for equity acquisition deals involving labs and diagnostics providers. Three key deals that…
From - Laboratory Industry Report
Less than a month after its acquisition of neonatal specialty lab Sequenom, LabCorp acquired obstetric and gynecology testing firm…
From - Laboratory Industry Report
Attendees at G2 Intelligence's 34th annual Lab Institute were treated to a history lesson about diagnostics as well as…
From - Laboratory Industry Report
An assay developed by a California-based laboratory that determines the levels of troponin could be used as a…